Skip to content

To evaluate the effect of Tila Tail Yonipichu with Amalaki Sita churna orally on Yonikandu in Pregnancy

Single arm open label clinical study to evaluate the effect of Tila Tail Yonipichu with Amalaki Sita churna orally on Yonikandu in Pregnancy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077773
Enrollment
30
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O988- Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant patient having signs and symptoms of Yonikandu will be taken irrespective of age parity and gestational age

Exclusion criteria

Exclusion criteria: Known case of Diabetes Mellitus Patient with VDRL and HIV Herpes genitalis Syphilis

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Tila Tail Yonipichu and Amalaki Sita churna orally on Yonikandu in pregnancyTimepoint: Treatment will be given for 7 consecutive days Tila Tail Yonipichu once a day for 7 consecutive days and Amalaki Sita churna orally two times a day for 7 consecutive days will be given to the patients Follow up & Assessment will be done Pre-treatment and on every 7 days of treatment and after completion of treatment and final observation will be recorded on 7th day

Secondary

MeasureTime frame
Literature Study Of Yonikandu In Pregnancy To Observe Adverse Effects If AnyTimepoint: Study Will Be Done Using Ayurvedic Granthas And Modern Texts Preparation Of Drugs Will Be Done According To Standard Procedure During Treatment Observation Will Be Done For Any Adverse Effect On Patients

Countries

India

Contacts

Public ContactDr.Chaitrali Somnath Tikhole

MAM’s Sumatibhai Shah Ayurved Mahavidyalaya

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026